Skip to main content

Peer Review reports

From: The role of ataluren in the treatment of ambulatory and non-ambulatory children with nonsense mutation duchenne muscular dystrophy - a consensus derived using a modified Delphi methodology in Eastern Europe, Greece, Israel and Sweden

Original Submission
7 Sep 2023 Submitted Original manuscript
29 Sep 2023 Author responded Author comments - Craig Dixon
9 Nov 2023 Reviewed Reviewer Report
16 Nov 2023 Reviewed Reviewer Report
11 Jan 2024 Author responded Author comments - Craig Dixon
Resubmission - Version 2
29 Sep 2023 Submitted Manuscript version 2
15 Jan 2024 Author responded Author comments - Craig Dixon
Resubmission - Version 3
15 Jan 2024 Submitted Manuscript version 3
12 Feb 2024 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
13 Feb 2024 Editorially accepted
21 Feb 2024 Article published 10.1186/s12883-024-03570-x

You can find further information about peer review here.

Back to article page